Here, we sought to identify immunological features in pancreatic cancers that predicted worse outcomes for patients and identified the combination of low CD8+ T cell infiltration and high PD-L1 expression (CD8+ TloPD- L1hi) as an adverse prognostic feature. Here, CD8A is linked to familial pancreatic carcinoma.